Tesamorelin / Ipamorelin 18mg (Blend)

Research description

In research environments, combining Tesamorelin and Ipamorelin peptides provides a complementary method for studying growth hormone regulation in test subjects. Tesamorelin is an analog of growth hormone–releasing hormone (GHRH) that promotes endogenous growth hormone secretion by acting at the pituitary level and supporting somatotropic axis activity. Ipamorelin is a growth hormone secretagogue (GHS/GHRP) and selective ghrelin receptor agonist that further enhances growth hormone release while aiming to limit off‑target effects such as elevations in cortisol or prolactin. Together, these peptides can be used to investigate growth hormone dynamics and related physiological responses under controlled laboratory conditions.

Summary of characteristics

Legal disclaimer

This material is supplied solely as a high‑purity research compound and is not intended for use as a dietary supplement or for any form of human or veterinary consumption. All purchasers are responsible for reviewing and complying with the terms and conditions prior to ordering.

Safety information

Keep this material out of the reach of children. Due to the limited body of research available, improper handling or use may lead to adverse effects. This compound is provided only as a raw research substance, and any use is restricted to individuals who possess the appropriate knowledge, training, and equipment to manage it safely. By purchasing or handling this material, you agree to assume all responsibility for its use and to indemnify the supplier against any negative outcomes resulting from mishandling or consumption.

Educational use notice

All articles and informational content related to this product are offered solely for educational and informational purposes. These materials are not drugs or medications, and they are not approved by the Food and Drug Administration to diagnose, treat, cure, or prevent any disease, condition, or ailment.